SELLAS Life Sciences

+$0.04 (+1.26%) As of 1:10 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline include galinpepimut-S and nelipepimut-S.

CEO
Angelos M. Stergiou
Employees
11
Headquarters
New York, New York
Founded
2006

SLS Key Statistics

Market cap
65.30M
Price-Earnings ratio
—
Dividend yield
—
Average volume
237.35K
High today
$3.24
Low today
$3.03
Open price
$3.10
Volume
105.43K
52 Week high
$15.08
52 Week low
$2.10

SLS Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$1.05 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure